Comments on: Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®

Comments on: Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair® https://9krapalm.com/superior-efficacy-and-long-acting-longbio-announces-positive-topline-results-from-phase-ii-csu-trial-of-next-generation-anti-ige-therapy-lp-003-in-head-to-head-comparison-with-xolair/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Mon, 02 Mar 2026 14:22:54 +0000 hourly 1 https://wordpress.org/?v=7.0